EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach

Rahim Jiwani, Koustav Pal iD, Iwan Paolucci iD, Bruno Odisio, Kristy Brock, Nizar M Tannir, Daniel D Shapiro, Pavlos Msaouel iD, Rahul A Sheth

The Oncologist · 06.02.2025 · 30 (2)

DOI: 10.1093/oncolo/oyae337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 18.02.2025. Verfasst von Rahim Jiwani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Hauptthemen laut MEDLINE: Machine Learning, Carcinoma, Renal Cell, Kidney Neoplasms, Carcinoma, Medullary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Andrew Sabin Family Foundation Fellowship, Translational Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to develop and validate a radiomics-based machine learning (ML) model to differentiate between renal medullary carcinoma (RMC) and clear cell renal carcinoma (ccRCC).

Methods

This retrospective Institutional Review Board -approved study analyzed CT images and clinical data from patients with RMC (n = 87) and ccRCC (n = 93). Patients without contrast-enhanced CT scans obtained before nephrectomy were excluded. A standard volumetric software package (MIM 7.1.4, MIM Software Inc.) was used for contouring, after which 949 radiomics features were extracted with PyRadiomics 3.1.0. Radiomics analysis was then performed with RadAR for differential radiomics analysis. ML was then performed with extreme gradient boosting (XGBoost 2.0.3) to differentiate between RMC and ccRCC. Three separate ML models were created to differentiate between ccRCC and RMC. These models were based on clinical demographics, radiomics, and radiomics incorporating hemoglobin electrophoresis for sickle cell trait, respectively.

Results

Performance metrics for the 3 developed ML models were as follows: demographic factors only (AUC = 0.777), calibrated radiomics (AUC = 0.915), and calibrated radiomics with sickle cell trait incorporated (AUC = 1.0). The top 4 ranked features from differential radiomic analysis, ranked by their importance, were run entropy (preprocessing filter = original, AUC = 0.67), dependence entropy (preprocessing filter = wavelet, AUC = 0.67), zone entropy (preprocessing filter = original, AUC = 0.67), and dependence entropy (preprocessing filter = original, AUC = 0.66).

Conclusion

A radiomics-based machine learning model effectively differentiates between ccRCC and RMC. This tool can facilitate the radiologist’s ability to suspicion and decrease the misdiagnosis rate of RMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningCarcinoma, Renal CellKidney NeoplasmsCarcinoma, MedullaryKidney MedullaHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTomography, X-Ray ComputedDiagnosis, DifferentialAdultRadiomics

Stichwörter der Autor:innen

clear cell renal carcinomaradiomicsrenal medullary carcinoma

Autor:innen und Institutionen

  • Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 77030, United States.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.

ORCID-Profile: Koustav Pal, Iwan Paolucci, Pavlos Msaouel

Förderung

  • NCI NIH HHS
  • Andrew Sabin Family Foundation Fellowship
  • Translational Research Award
  • Translational Research Partnership Award
  • Advanced Discovery Award
  • Kidney Cancer Association
  • Johnson Foundation
  • United States Department of Defense

Zitieren

APA

Jiwani, R., Pal, K., Paolucci, I., Odisio, B., Brock, K., Tannir, N. M., Shapiro, D. D., Msaouel, P., & Sheth, R. A. (2025). Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach. The Oncologist, 30(2). https://doi.org/10.1093/oncolo/oyae337

Vancouver

Jiwani R, Pal K, Paolucci I, Odisio B, Brock K, Tannir NM, et al. Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach. The Oncologist. 2025;30(2). doi:10.1093/oncolo/oyae337

BibTeX
@article{Jiwani2025,
  author = {Jiwani, Rahim and Pal, Koustav and Paolucci, Iwan and Odisio, Bruno and Brock, Kristy and Tannir, Nizar M and Shapiro, Daniel D and Msaouel, Pavlos and Sheth, Rahul A},
  title = {Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach},
  journal = {The Oncologist},
  year = {2025},
  volume = {30},
  number = {2},
  doi = {10.1093/oncolo/oyae337}
}
Kostenlos starten →